Human medicines European public assessment report (EPAR): Renagel, sevelamer, Date of authorisation: 28/01/2000, Revision: 38, Status: Authorised

Submitted by Anonymous (not verified) on 22 January 2025 - 15:36

Human medicines European public assessment report (EPAR): Renagel, sevelamer, Date of authorisation: 28/01/2000, Revision: 38, Status: Authorised

Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests

Submitted by Anonymous (not verified) on 22 January 2025 - 14:23

Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests

Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 22 January 2025 - 13:51

Human medicines European public assessment report (EPAR): Lytenava, bevacizumab, Date of authorisation: 27/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa,carbidopa,entacapone, Date of authorisation: 23/08/2011, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 22 January 2025 - 13:41

Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa,carbidopa,entacapone, Date of authorisation: 23/08/2011, Revision: 15, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More